Figure 1 | Scientific Reports

Figure 1

From: Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy

Figure 1

Stage at diagnosis and BMI status affect survival rates in patients that achieved pathological complete response after neoadjuvant chemotherapy. (A) Overall survival (OS) curves comparing stage I/II versus stage III (LogRank p = 0.0019). (B) OS curves comparing non-obese versus obese (LogRank p = 0.0024). (C) Breast cancer specific survival (BCSS) curves comparing stage I/II versus stage III (LogRank p = 0.0027). (D) BCSS curves comparing non-obese versus obese (LogRank p = 0.037). E. Distant disease-free survival (DDFS) curves comparing stage I/II versus stage III (LogRank p = 0.0015). (F) DDFS curves comparing non-obese versus obese (LogRank p = 0.045). (G) Invasive-disease free survival (IDFS) curves comparing stage I/II versus stage III (LogRank p = 0.0018). (H) IDFS curves comparing non-obese versus obese (LogRank p = 0.019).

Back to article page